bioRxivMolecular BiologyPreprint
The molecular landscape of polycystic kidneys is marked by common alterations in purine metabolism
Jean-Paul DecuypereiD, Daniel BorràsiD, Priyanka Joseph KoshyiD, Ludwig Missiaen, Steffen FieuwsiD, Nikky CorthoutiD, Humbert DE SMEDTiD, Diethard R.L. MonbaliuiD, Jacques PirenneiD, Tania RoskamsiD, Bart GhesquièreiD, Bert BammensiD, Abhishek Dinkarnath GargiD, Djalila MekahliiD, Rudi VennekensiD
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease. Cysts develop through dedifferentiation of tubular epithelial cells, but the sequence of molecular events and their relative importance remain unclear. To address this gap in knowledge, 40 cysts from 4 ADPKD kidneys and 4 microcystic tissues were mapped on transcriptomic and histological level. Cyst were heterogenous and we identified 6 cystic subclusters with 2 deviations from the main trajectory, dependent on the rate of interstitial remodeling, inflammation and dedifferentiation. Loss of proximal tubular marker gene expression was more pronounced compared to those of other tubular segments. Altered expression of metabolic pathways was consistent among the cysts, which was further analyzed in human and mouse cell lines. Purine metabolism was similarly altered in all ADPKD cell lines, and its modulation with azathioprine suppressed cyst formation in vitro. In conclusion, by focusing on common altered pathways in cysts and cell models, we have identified purine metabolism as a novel potential target in ADPKD.
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Endoplasmic reticulum-mitochondrion disconnection promotesmetabolic reprogramming and cystogenesis in polycystic kidneydisease
Biswajit Padhy, Jian Xie, … Chou‐Long Huang·bioRxiv·Oct 31, 2025
- c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease
Abigail O. Smith, Julie A. Jonassen, … Gregory J. Pazour·PLoS GeneticsPeer-reviewed·Dec 28, 2021
- Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKD
Ming Wu, Yanzhe Wang, … Chaoyang Ye·bioRxiv·Nov 3, 2021
- The Tryptophan Metabolizing Enzyme Indoleamine 2,3-Dioxygenase 1 Regulates Polycystic Kidney Disease Progression
Dustin T. Nguyen, Emily K. Kleczko, … Katharina Hopp·JCI InsightPeer-reviewed·Nov 24, 2022
- Targeting Ogt in ADPKD mitigates metabolic reprogramming and renal cystogenesis, extending survival
Matthew A. Kavanaugh, Saleem Ahmad, … Pamela Vivian Tran·bioRxiv·Dec 16, 2025
- Anti-Polyamine Therapy Restrains Kidney Cyst Growth in an Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease
Katharina Hopp, Marie‐Louise T. Monaghan, … Katherine I. Swenson-Fields·bioRxiv·Jun 5, 2026